Apotex Accuses Amgen Of Sham Patent Litigation
Canadian generics maker Apotex Inc. fired back in Florida federal court Monday with counterclaims accusing Amgen Inc. of filing sham litigation alleging Apotex infringed two patents for blockbuster biologic Neulasta....To view the full article, register now.
Already a subscriber? Click here to view full article